• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.67% Nasdaq Up1.47%

    Ultragenyx Pharmaceutical Inc. (RARE)

    -NasdaqGS
    86.74 Up 4.10(4.96%) 4:00PM EDT
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):1.6
    Mean Recommendation (last week):1.6
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:77.50
    Median Target:77.50
    High Target:82.00
    Low Target:73.00
    No. of Brokers:8

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Mar 31, 2015MLV & CoInitiated Buy
    Feb 25, 2014Canaccord GenuityInitiated Buy
    Aug 27, 2007BB&T Capital MktsDowngradeBuyHold
    Aug 17, 2007KeyBanc Capital Mkts / McDonaldDowngradeBuyHold
    Feb 16, 2007Sun Trust Rbsn HumphreyUpgradeNeutralBuy
    Feb 15, 2007RBC Capital MktsDowngradeOutperformSector Perform
    Jan 18, 2007JP MorganDowngradeOverweightNeutral
    Jan 17, 2007PrudentialInitiated Neutral
    Nov 14, 2006Robert W. BairdInitiated Neutral
    Sep 8, 2006Jefferies & CoInitiated Buy

    More Upgrades & Downgrades for RARE

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy0000
    Buy0000
    Hold0000
    Underperform0000
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.